Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Return on Capital Employed (2018 - 2025)

Lexaria Bioscience's Return on Capital Employed history spans 8 years, with the latest figure at 2.94% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 214.0% year-over-year to 2.94%; the TTM value through Nov 2025 reached 2.94%, down 214.0%, while the annual FY2025 figure was 2.36%, 118.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 2.94% at Lexaria Bioscience, up from 3.0% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 6.39% in Q2 2023 and bottomed at 38.38% in Q2 2024.
  • The 5-year median for Return on Capital Employed is 1.11% (2025), against an average of 4.31%.
  • The largest annual shift saw Return on Capital Employed crashed -4478bps in 2024 before it soared 3655bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.57% in 2021, then crashed by -69bps to 0.96% in 2022, then crashed by -328bps to 4.11% in 2023, then soared by 80bps to 0.81% in 2024, then plummeted by -264bps to 2.94% in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Return on Capital Employed are 2.94% (Q4 2025), 3.0% (Q3 2025), and 1.83% (Q2 2025).